DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20193198

A world health organization core drug use indicator based prescription study in the dermatology outpatient department of a tertiary care teaching hospital of central South India

Mahendra K. Jaiswal, Rajnesh K. Chakrawarty, Sanat K. Sharma, Raj K. Sharma, Rupendra K. Bharti, Ratna Agrawal

Abstract


Background: Irrational prescribing is a universal problem that may lead to inadequate response to medication therapy, poor patient compliance and increased adverse drug reactions ultimately leading to frequent hospital admissions. Hence this study was done to assess the drug utilization pattern using WHO core drug use indicators so that the recommendation can be made towards the rational prescribing.

Methods: A sample of 3650 prescriptions was analysed prospectively to assess the drug utilization patterns in the dermatology OPD of a tertiary care teaching hospital of central south India.

Results: The average number of drugs per prescription was 2.74 whereas 79.26% drugs were prescribed by generic names. Percentage of encounters with an antibiotic prescribed was 18.68%. Regarding use of injections, 3.26% prescriptions contains one or more injections. Percentage of drugs prescribed from essential drugs list was 78.37%. Average consultation time was lower (2.9 minutes) than recommended.

Conclusions: The data from the present study indicates that prevalence of polypharmacy, inadequate consultation and dispensing time along with poor patient’s knowledge are the areas of medication therapy to be improved. Availability of essential drugs and key drugs in stock should be improved to achieve rational therapeutic goal. Further, continued medical education regarding the rational prescribing will definitely improve the standards of health care delivery.


Keywords


Dermatology, Essential drug list, Polypharmacy, Prescription analysis, WHO core drug use indicators

Full Text:

PDF

References


Definition of Prescription. Available at: https://en.oxforddictionaries.com/definition/prescription. Accessed 21 March 2019.

Caplan, Jeremy. "Cause of Death: Sloppy Doctors". Time. Jan. 15, 2007. Available at: http://content.time.com/time/health/article/0,8599,1578074,00.html. Accessed 21 March 2019.

Badyal D. Practical Manual of Pharmacology. 1st ed. Jaypee Brothers Medical Publishers, New Delhi; 2008: 112.

Velo GP, Minuz P. Medication errors: prescribing faults and prescription errors. Br J Clin Pharmacol. 2009 Jun;67(6):624-628.

Folli HL, Poole RL, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987 May 1;79(5):718-22.

Blum KV, Abel SR, Urbanski CJ, Pierce JM. Medication error prevention by pharmacists. Am J Hosp Pharm. 1988 Sep 1;45(9):1902-3.

Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA. 1997 Jan 22;277(4):312-7.

Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995 Jul 5;274(1):29-34.

American Society of Health-System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions. Am J Health Syst Pharm. 1998 Jan 15;55(2):165-6.

Sweileh WM. Audit of prescribing practices of topical corticosteroids in outpatient dermatology clinics in north Palestine. Eastern Mediterr Health J. 2006;12(1/2):161-9.

World Health Organization. How to Investigate Drug Use in Health Facilities. Selected Drug Use Indicators. Geneva: WHO; 1993. Available at: http://apps.who.int/medicinedocs/en/d/Js2289e/. Accessed 21 March 2019.

C.G. Essential drug list 5th edition June 2016. Department of Health and Family Welfare. Government of Chhattisgarh. India.

Bijoy KP, Vidyadhar RS, Palak P, Chintan SP, Atmaram PP. Drug prescribing and economic analysis for skin diseases in dermatology OPD of an Indian tertiary care teaching hospital: a periodic audit. Ind J Pharm Pract. 2012;5(1):28-33.

Narwane SP, Patel TC, Shetty YC, Chikhalkar SB. Drug utilization and cost analysis for common skin diseases in dermatology OPD of an Indian tertiary care hospital-A prescription survey. Br J Pharm Res. 2011;1(1):9-18.

Sarkar C, Das B, Sripathi H. Drug prescribing pattern in dermatology in a teaching hospital in western Nepal. J Nepal Med Assoc. 2001;41:241-6.

Das S, Chatterjee T. Pattern of skin diseases in a peripheral hospital's skin OPD: A study of 2550 patients. Ind J Dermatol. 2007 Apr 1;52(2):93.

Symvoulakis EK, Krasagakis K, Komninos ID, Kastrinakis I, Lyronis I, Philalithis A, Tosca AD. Primary care and pattern of skin diseases in a Mediterranean island. BMC Fam Pract. 2006 Dec;7(1):6.

Baur B, Sarkar J, Manna N, Bandyopadhyay L. The pattern of dermatological disorders among patients attending the skin OPD of a tertiary care hospital in Kolkata, Ind J Dent Med Sci. 2013;3(4):04-9.

Rao GS, Kumar SS, Sandhya S. Pattern of skin diseases in an Indian village. Indian J Med Sci, 2003;57(3):108-10.

Sajith M, Lokhande KD, Padma S, Pawar AP. Prevalance of various skin disorders and prescribing pattern of antihistamines in tertiary care hospital, Pune. Int J Pharm Sci Res. 2014;5(03):73-7.

Pathak AK, Kumar S, Kumar M, Mohan L, Dikshit H. Study of drug utilization pattern for skin diseases in dermatology OPD of an Indian tertiary care hospital-A prescription survey. J Clin Diagn Res: JCDR. 2016 Feb;10(2):FC01-5.

Guide to Drug Financing Mechanisms. 1998 WHO. Available at: https://apps.who.int/medicinedocs/en/d/Jh2928e/#Jh2928e. Accessed 21 March 2019.

Sheppard A. Generic Medicines: Essential contributors to the long-term health of society. Ims Health. 2010 Mar;16.

Akl OA, El Mahalli AA, Elkahky AA, Salem AM. WHO/INRUD drug use indicators at primary healthcare centers in Alexandria, Egypt. J Taibah Univ Med Sci. 2014;9(1):54-64.